Shelter Pharma Ltd.

As of March 31, 2026, Shelter Pharma Ltd. carries a market capitalization of 445.69M, placing it among publicly traded companies globally. Its enterprise value stands at 442.92M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Shelter Pharma Ltd. has 16.61M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Shelter Pharma Ltd. maintains a current ratio of 7.86, meaning it holds 7.9x the short-term assets needed to cover near-term liabilities.

As of the close on October 22, 2026, Shelter Pharma Ltd.'s stock has gained approximately 7.43% over the past 52 weeks. The 50-day moving average sits at 35.74, while the 200-day moving average is 33.39.

As of March 31, 2026, Shelter Pharma Ltd. holds 10.79M in cash and equivalents against 8.01M in total debt, resulting in a net debt position of -2.78M. Total book value stands at 766.32M, with working capital of 480.49M providing operational flexibility.